Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
Udo Rüb, Lüdger Schöls, Henry L. Paulson, et al.
Progress in Neurobiology (2013) Vol. 104, pp. 38-66
Closed Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

Tandem repeats mediating genetic plasticity in health and disease
Anthony J. Hannan
Nature Reviews Genetics (2018) Vol. 19, Iss. 5, pp. 286-298
Closed Access | Times Cited: 381
Polyglutamine spinocerebellar ataxias — from genes to potential treatments
Henry L. Paulson, Vikram G. Shakkottai, H. Brent Clark, et al.
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 10, pp. 613-626
Open Access | Times Cited: 330
Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
Adriana Marcelo, Rebekah Koppenol, Luís Pereira de Almeida, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 132
Polyglutamine (PolyQ) Diseases: Genetics to Treatments
Hueng-Chuen Fan, Li-Ing Ho, Ching-Shiang Chi, et al.
Cell Transplantation (2014) Vol. 23, Iss. 4-5, pp. 441-458
Open Access | Times Cited: 180
Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain
Udo Rüb, Kay Seidel, Helmut Heinsen, et al.
Brain Pathology (2016) Vol. 26, Iss. 6, pp. 726-740
Open Access | Times Cited: 166
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice
Hayley S. McLoughlin, Lauren R. Moore, Ravi Chopra, et al.
Annals of Neurology (2018) Vol. 84, Iss. 1, pp. 64-77
Open Access | Times Cited: 142
Pathogenesis of SCA3 and implications for other polyglutamine diseases
Hayley S. McLoughlin, Lauren R. Moore, Henry L. Paulson
Neurobiology of Disease (2019) Vol. 134, pp. 104635-104635
Open Access | Times Cited: 135
Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS)
David J. Szmulewicz, L. Jackson Roberts, Catriona McLean, et al.
Neurology Clinical Practice (2016) Vol. 6, Iss. 1, pp. 61-68
Open Access | Times Cited: 127
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
Lauren R. Moore, Gautam Rajpal, Ian T. Dillingham, et al.
Molecular Therapy — Nucleic Acids (2017) Vol. 7, pp. 200-210
Open Access | Times Cited: 127
Spinocerebellar ataxia: relationship between phenotype and genotype – a review
Yang Sun, C. Lu, Zhi‐Ying Wu
Clinical Genetics (2016) Vol. 90, Iss. 4, pp. 305-314
Closed Access | Times Cited: 124
The preclinical stage of spinocerebellar ataxias
Roderick P.P.W.M. Maas, Judith van Gaalen, Thomas Klockgether, et al.
Neurology (2015) Vol. 85, Iss. 1, pp. 96-103
Closed Access | Times Cited: 123
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Ronald A.M. Buijsen, Lodewijk J.A. Toonen, Sarah L. Gardiner, et al.
Neurotherapeutics (2019) Vol. 16, Iss. 2, pp. 263-286
Open Access | Times Cited: 116
Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich’s ataxia
Maria R. Stefanescu, M. Dohnalek, Stefan Maderwald, et al.
Brain (2015) Vol. 138, Iss. 5, pp. 1182-1197
Open Access | Times Cited: 112
Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
Megan S. Keiser, Holly Kordasiewicz, Jodi L. McBride
Human Molecular Genetics (2015) Vol. 25, Iss. R1, pp. R53-R64
Open Access | Times Cited: 108
Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability
James Dell’Orco, Aaron H. Wasserman, Ravi Chopra, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 32, pp. 11292-11307
Open Access | Times Cited: 105
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1
Marija Cvetanović, Martha-Conley E. Ingram, Harry T. Orr, et al.
Neuroscience (2015) Vol. 289, pp. 289-299
Open Access | Times Cited: 102
Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs
Yoshihito Ishida, Hideshi Kawakami, Hiroyuki Kitajima, et al.
Cell Reports (2016) Vol. 17, Iss. 6, pp. 1482-1490
Open Access | Times Cited: 101
Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1
Ricardo Mouro Pinto, Larissa Arning, James Victor Giordano, et al.
Human Molecular Genetics (2020) Vol. 29, Iss. 15, pp. 2551-2567
Open Access | Times Cited: 99
Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation
Isabel Lastres‐Becker, David Nonis, Florian Eich, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1862, Iss. 9, pp. 1558-1569
Open Access | Times Cited: 91
Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes
Isaac Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, et al.
NeuroImage Clinical (2018) Vol. 19, pp. 858-867
Open Access | Times Cited: 91
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
Lodewijk J.A. Toonen, Frank Rigo, Haico van Attikum, et al.
Molecular Therapy — Nucleic Acids (2017) Vol. 8, pp. 232-242
Open Access | Times Cited: 89
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
Carlo Wilke, Eva Haas, Kathrin Reetz, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 7
Open Access | Times Cited: 88
Consensus Paper: Novel Directions and Next Steps of Non-invasive Brain Stimulation of the Cerebellum in Health and Disease
Mario Manto, Georgios P. D. Argyropoulos, Tommaso Bocci, et al.
The Cerebellum (2021) Vol. 21, Iss. 6, pp. 1092-1122
Closed Access | Times Cited: 59
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2665-2694
Open Access | Times Cited: 11
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease
Rafael G. Costa, André Conceição, Carlos A. Matos, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top